Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

2.50
Delayed Data
As of Dec 09
 -0.15 / -5.66%
Today’s Change
2.30
Today|||52-Week Range
6.93
-53.70%
Year-to-Date
TrovaGene Inks Contract with Boreal Genomics, Stock Down
Dec 01 / Zacks.com - Paid Partner Content
TrovaGene (TROV) Precision Cancer Monitoring Data Positive
Nov 29 / Zacks.com - Paid Partner Content